Chase AIPricingFAQs
Display currency
Loading news…

Alteron Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Kalamazoo, Michigan, United States Founded 2017 1-10 employees For Profit

Alteron Therapeutics develops small molecule therapies targeting TDP-43 for neurodegenerative and related diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
3
Patents
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
0
Patents granted
1
Trademarks
0
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
IT spend
$23K

Company Info

Founded
2017
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
HQ
Kalamazoo, Michigan, United States
Region
Great Lakes, Midwestern US

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.1
Trend (30d)
1.2
Trend (90d)
2.9
3
professional contacts at Alteron Therapeutics
Contact execs at Alteron Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Alteron Therapeutics

Loading news…

FAQs about Alteron Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Alteron Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments